Check the

ENDOSCAN LIMITED

Company
ENDOSCAN LIMITED (02084432)

ENDOSCAN

Phone: 01323 371 791
A⁺ rating

ABOUT ENDOSCAN LIMITED

A dedication to technical excellence is one of our primary mission objectives and we retain the services of eminent consultants in optical design, nuclear, electronics and electrical engineering.

Visual solutions are provided for all inspection, condition monitoring, investigation and security applications.

Within the specialist endoscope market, Endoscan has achieved a worldwide reputation for its high quality products.

Endoscan's customer portfolio includes numerous blue chip companies and organisations, ranging from Aerospace to Nuclear, Industrial, Security and Government organisations, with whom we co-operate on a regular basis.

All Endoscan endoscopes are manufactured at our UK factory in Burgess Hill West Sussex which also contains a controlled environment clean room, together with precision engineering and assembly facilities. This facility also enables us to provide a fast efficient repair and support service.

We have the capability to work closely with engineers, scientists and technologists, to interpret their needs for remote vision systems and to provide the hardware solutions.

Endoscan has been granted quality systems approvals in industrial engineering since 1998 and current conformance is to

Endoscan Ltd. Unit 2 Avocet Industrial Estate, Victoria Gardens, Burgess Hill, West Sussex, RH15 9NH

KEY FINANCES

Year
2017
Assets
£400.93k ▲ £86.35k (27.45 %)
Cash
£7.32k ▼ £-25.41k (-77.64 %)
Liabilities
£36.75k ▼ £-4.67k (-11.27 %)
Net Worth
£364.18k ▲ £91.02k (33.32 %)

REGISTRATION INFO

Company name
ENDOSCAN LIMITED
Company number
02084432
Status
Active
Categroy
Private Limited Company
Date of Incorporation
16 Dec 1986
Age - 38 years
Home Country
United Kingdom

CONTACTS

Website
endoscan.co.uk
Phones
01323 371 791
07926 519 185
02074 832 300
01444 871 488
01444 239 111
Registered Address
MARLBRIDGE HOUSE,
ENTERPRISE WAY,
EDENBRIDGE,
KENT,
TN8 6HF

ECONOMIC ACTIVITIES

32990
Other manufacturing n.e.c.

THIS BUSINESS IN SOCIAL MEDIA

Twitter
Follow

LAST EVENTS

27 Dec 2016
Confirmation statement made on 28 November 2016 with updates
25 Oct 2016
Total exemption small company accounts made up to 31 March 2016
03 Dec 2015
Annual return made up to 28 November 2015 with full list of shareholders Statement of capital on 2015-12-03 GBP 940

CHARGES

5 April 1991
Status
Outstanding
Delivered
24 April 1991
Persons entitled
Barclays Bank PLC
Description
Land lying to the south of victoria road burgess hill west…

10 June 1987
Status
Outstanding
Delivered
17 June 1987
Persons entitled
Barclays Bank PLC
Description
Fixed and floating charges over the undertaking and all…

See Also


Last update 2018

ENDOSCAN LIMITED DIRECTORS

Anthony John Duncan

  Acting
Occupation
Director
Role
Secretary
Nationality
British
Address
11 St Johns Wood Court, St Johns Wood Road, London, NW8 8QT
Name
DUNCAN, Anthony John

Anthony John Duncan

  Acting PSC
Occupation
Director
Role
Director
Age
86
Nationality
British
Address
11 St Johns Wood Court, St Johns Wood Road, London, NW8 8QT
Country Of Residence
England
Name
DUNCAN, Anthony John
Notified On
7 April 2016
Nature Of Control
Has significant influence or control

Olga Alexandrova Duncan

  Acting
Occupation
Director - Translation
Role
Director
Age
72
Nationality
British
Address
11 St Johns Wood Court, St Johns Wood Road, London, NW8 8QT
Country Of Residence
United Kingdom
Name
DUNCAN, Olga Alexandrova

Stephen John Duncan

  Acting
Appointed
01 July 2012
Occupation
Director
Role
Director
Age
57
Nationality
British
Address
Marlbridge House, Enterprise Way, Edenbridge, Kent, United Kingdom, TN8 6HF
Country Of Residence
United Kingdom
Name
DUNCAN, Stephen John

Anthony Charles Grantham

  Resigned
Resigned
31 December 2014
Occupation
Engineer
Role
Director
Age
77
Nationality
British
Address
24 Kingsmead, Smallfield, Horley, Surrey, RH6 9QR
Country Of Residence
United Kingdom
Name
GRANTHAM, Anthony Charles

REVIEWS


Check The Company
Excellent according to the company’s financial health.